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Introduction
Thromboembolic disease is one of the leading causes
of maternal mortality and morbidity. It has been re-
ported to occur in 1 in 1,000 to 1 in 2,000 pregnancies
[1]. Recently, several authors have reported ovarian
hyperstimulation-associated thromboembolic disorders
[2–7], with an estimated prevalence of 1 in 128 women
exhibiting severe ovarian hyperstimulation syndrome
(OHSS) reported by Delvigne et al [8]. This observation
is of particular interest in preventing such potentially
fatal yet completely iatrogenic complications in preg-
nant women with mixed risk factors by maintaining a
high index of suspicion to avoid delayed diagnosis and
treatment. We describe a patient with an extensive
thrombosis of the superior vena cava (SVC) that was
thought to occur following ovulation induction with
gonadotropins and subsequent OHSS. To our know-
ledge, this is the first reported case of spontaneous SVC
thrombosis associated with OHSS in a triplet pregnancy
in the English literature.
Case Report
A 30-year-old nulligravida presented with a 3-year his-
tory of primary infertility because of tubal disease. The
history was unremarkable for intravenous drug abuse
and personal or family history of thromboembolic
disorders. She was given one cycle of clomiphene
citrate 100 mg daily, on cycle days 3–7, and a total of
six ampoules of human menopausal gonadotropin
SUMMARY
Objective: Thromboembolism associated with assisted reproductive techniques (ART) is extremely rare. We
report a case of thrombosis of the entire superior vena cava associated with severe ovarian hyperstimulation
syndrome (OHSS) after ovulation induction with gonadotropins in a triplet pregnancy.
Case Report: A 30-year-old woman became pregnant with triplets following human menopausal gonadotropin-
induced ovarian stimulation and subsequent artificial insemination with husband’s sperm (AIH). She developed
an extensive thrombosis of the entire superior vena cava as a late complication of severe OHSS 10 weeks after
AIH and was successfully treated with heparin. Two male infants weighing 760 g and 810 g, both with Apgar
scores of 3 and 5 at 1 and 5 minutes, respectively, were delivered by cesarean section. Postoperative convalescence
was uneventful and both infants were doing well at 6 years of age.
Conclusion: The present case report highlights the importance of preventing this potentially dreadful yet
completely iatrogenic thromboembolic complication with appropriate heparin therapy throughout pregnancy,
particularly in patients with mixed risk factors associated with ART and OHSS. [Taiwanese J Obstet Gynecol 2005;
44(3):281–283]
Key Words: ovarian hyperstimulation syndrome, superior vena cava thrombosis, triplet pregnancy
■  SHORT COMMUNICATION  ■
S.Y. Lin, et al
Taiwanese J Obstet Gynecol • September 2005 • Vol 44 • No 3282
(Humegon, Organon, Oss, The Netherlands) starting
on day 5 at a local clinic. A total of 12 follicles measuring
16–22 mm in diameter were noted. Thirty-six hours
after administration of human chorionic gonadotropin
(hCG) (Pregnyl, Organon) 10,000 IU, artificial insemin-
ation with husband’s sperm (AIH) was carried out.
Two weeks later, the patient complained of lower
abdominal discomfort. Transvaginal ultrasound
examination revealed a moderate amount of ascites
and both ovaries enlarged to 6 cm in diameter. Three
gestational sacs were documented. The patient was
treated with bed rest and oral hydration by her local
clinician, and clinical symptoms and signs of OHSS
improved.
Nine weeks later, however, she presented with swollen
and painful right arm, neck and face. On examination,
the right arm was swollen with engorged veins and
venules across the chest, upper arms and neck. A clinical
diagnosis of right SVC syndrome (SVCS) was made at
the local hospital. Magnetic resonance imaging (MRI)
demonstrated an extensive high-signal thrombus
occluding the entire SVC (Figure A). There was only a
small peripheral patent lumen of less than about 10% of
the cross-sectional area on the axial plane (Figure B).
There was no mediastinal lymphadenopathy. Very
prominent collateral veins were noted in the media-
stinum, chest wall, lower neck, and paraspinal regions.
She was promptly treated with intravenous heparin
infusion therapy (25,000 IU/day) for 2 weeks, and
subsequently with subcutaneous heparin after having
learned to self-inject heparin (fraxiparine, 7,500 IU
twice daily). There was a good symptomatic response to
heparin treatment.
Unfortunately, at 18 weeks of gestation, the clinical
symptoms and signs of SVCS exacerbated. She under-
went selective termination of triplet A in a tertiary hos-
pital at 19 weeks because the attending physician was
concerned about the mechanical compression effect
produced by an enlarged uterus. Repeat MRI exam-
ination revealed unremarkable changes compared with
prior MRI findings. Because tumor thrombosis was
suspected by the radiologist and hematologist, the
patient underwent cardiac catheterization, which
revealed occlusion at the junction of the right subclavian
vein and right internal jugular vein with prominent
collaterals. An aspiration sample from the SVC was
negative for malignant cells on cytologic examination.
At 25 weeks of gestation, she self-referred to our
institution for further management. Tocolytic treat-
ment with ritodrine hydrochloride infusion and steroid
treatment to accelerate fetal lung maturation were given
because of preterm labor. However, despite tocolytic
treatment, the patient went into active labor. A female
stillbirth weighing 200 g and two male infants weighing
760 g and 810 g, both with Apgar scores of 3 and 5 at
1 and 5 minutes, respectively, were delivered by cesarean
section. Intravenous heparin treatment was restarted
24 hours after cesarean delivery and continued with
warfarin 5 days later. Repeat MRI examination of the
SVC performed 3 months postpartum revealed re-
canalization and that most clots within the SVC had
resolved. A full thrombophilia screen including anti-
thrombin III, protein C and S, homocysteine, anticardio-
lipin antibodies, and lupus anticoagulant was within
normal limits. The patient and both infants were doing
well 6 years later.
Figure. (A) SE 4000/94 coronal image. An extensive high-
signal thrombus occludes the entire superior vena cava. (B) SE
450/15 transaxial image. The superior vena cava is almost
completely narrowed by the thrombus and there is only a small
peripheral patent lumen less than about 10% in cross-sectional
area.
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Discussion
Thromboembolic disease associated with ovarian
stimulation and assisted reproductive techniques (ART)
was first described in 1964 by Crooke et al. Since then,
at least 54 cases have been reported [6]. Of these,
66% were associated with OHSS. Most thromboses
reported were at venous sites (75%), 60% of which
were in the upper limb or neck and head veins [6].
The mean timing of venous thrombosis from hCG
administration is 38 days (range, 11–70 days) [6]. In
contrast, venous thrombosis during pregnancy most
frequently begins in the calf veins or the iliofemoral
segment of the deep venous system, and the risk
has been traditionally thought to be greater in the
puerperium and during the late third trimester [1].
There is no clear explanation for the propensity to
produce thromboses in unusual sites in OHSS and
ART patients, but it presumably occurs due to the
hypercoagulable state [5,6]. It has been shown that
significant changes in the coagulation and fibrinolytic
systems are induced by ART, and the dynamic equili-
brium between the two systems seem to lean towards
the coagulation part of the equilibrium [9]. We
emphasize the need for further research into the etiology
and pathogenesis of thromboembolic complications
following ART and OHSS.
Pregnant women at greatest risk for thromboembo-
lism include those who are immobilized, smoke, have a
positive personal or family history of thromboembolic
disease, develop OHSS with pregnancy, or who have
antiphospholipid syndrome, inherited thrombophilia
disorders including protein C or S or antithrombin III
deficiency, activated protein C resistance, or hyper-
homocysteinemia [10,11]. An emerging concept for
thrombosis occurrence is the synergistic effect of mul-
tiple hereditary and acquired risk factors in a single
individual. Although we were unable to test for factor
V Leiden mutation in this patient, we believe it is very
likely that the SVC thrombosis was caused by OHSS
and ART for three reasons. First, the literature contains
numerous reports of upper limb thrombosis associated
with OHSS and ART [2–12]. Second, neither the patient
nor her relatives had a history of thromboembolic
disease. Third, factor V Leiden mutation is very common
among Caucasians (3–7%), but is very uncommon in
Asians [10].
ART with hormonal stimulation may cause serious
complications in patients with unknown coagulation
disorders or OHSS [11]. The etiology of vascular
thrombosis with OHSS is unclear. Thus, preventive
measures for reducing the risk of thrombosis seems
appropriate [12]. These include the identification of
patients at increased risk for developing OHSS, more
extensive investigation of potential underlying coagu-
lopathy in severe or recurrent cases, and consideration
of prophylactic subcutaneous heparin or intravenous
albumin supplementation [12]. At all times, a high
index of suspicion should be maintained for cases of
unusually sited thromboses to avoid delayed diagnosis
and treatment of what is a potentially fatal yet completely
iatrogenic condition caused by ovarian stimulation and
ART.
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